Fig. 1From: Clients’ experiences on North America’s first take-home injectable opioid agonist treatment (iOAT) program: a qualitative studyThe four resultant themes from an interpretive description analysis of twenty-seven qualitative interviews with eleven participants1 (Charlie, Round 2); 2 (Jessie, Round 1); 3 (Reese, Round 1); 4 (Peyton, Round 2)Back to article page